Carafate is a branded medication for duodenal ulcers that may occur due to gastritis. Carafate protects ulcers from further attack by acid and enzymes in the stomach. Gastritis causes inflammation in ...
Although the mechanism of sucralfate’s ability to accelerate healing of duodenal ulcers remains to be fully defined, it is known that it exerts its effect through a local, rather than systemic, action ...
BRIDGEWATER, NJ.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (NYSE: AMRX), today announced that it has received final U.S. Food and Drug Administration approval on its Abbreviated New Drug ...
WASHINGTON D.C: Children usually swallow small items like button batteries, leading to caustic Esophageal injuries. Honey may help! A study by Kris Jatana of Nationwide Children's Hospital proved that ...
DUBLIN, Jan. 27, 2020 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that one of its operating companies, Par Pharmaceutical (Par), has begun shipping an authorized generic ...
The product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Carafate 1gm/10mL of AbbVie. Sucralfate is used to treat stomach ulcers, gastroesophageal reflux disease ...
Susp: administer by oral route only; do not give intravenously. Monitor for glycemia in diabetic patients. Chronic renal failure. Dialysis. Tabs: swallowing impairment (eg, recent or prolonged ...